Company Filing History:
4 out of 531 
1 out of 3,539 
Years Active: 2014-2024
Title: Ventzislav Bojidarov Vassilev: Innovator in Immunization and Vaccine Development
Introduction
Ventzislav Bojidarov Vassilev is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunization and vaccine development, holding a total of 4 patents. His work focuses on innovative approaches to combat chronic hepatitis B and influenza virus infections.
Latest Patents
Vassilev's latest patents include groundbreaking inventions in the realm of immunogenic compositions. One of his notable patents is for a hepatitis B immunization regimen and compositions. This invention relates to immunogenic compositions that may be utilized in immunization regimens for treating chronic hepatitis B. The composition includes a replication-defective chimpanzee adenoviral (ChAd) vector that encodes HBs and HBc, as well as a Modified Vaccinia Virus Ankara (MVA) vector. Additionally, he has developed another immunogenic composition that comprises recombinant HBs, C-terminal truncated recombinant HBc, and an adjuvant containing MPL and QS-21. Furthermore, he has patented novel influenza antigens, which include recombinant forms of hemagglutinin (HA) and their applications in vaccine compositions aimed at preventing influenza virus infections.
Career Highlights
Throughout his career, Vassilev has worked with prominent organizations such as GlaxoSmithKline Biologicals and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these esteemed institutions has allowed him to contribute significantly to vaccine research and development.
Collaborations
Vassilev has collaborated with several professionals in his field, including Virginie Van Scherpenzeel Thim and Normand Blais. These collaborations have further enhanced his research and innovation efforts in immunization.
Conclusion
Ventzislav Bojidarov Vassilev is a distinguished inventor whose work in immunization and vaccine development has the potential to impact public health significantly. His innovative patents and collaborations reflect his commitment to advancing medical science and improving health outcomes.